metaPreg - Domperidone during pregnancy

Domperidone updated on 06-01-2020

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	1.10 [0.36, 3.39]	0%	2 studies	14	232	not evaluable	ROB	-
Major congenital malformations	1.10 [0.36, 3.39]	0%	2 studies	14	232	not evaluable	ROB	-
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Jaundice / Icterus	0.43 [0.05, 3.51]	-	1 study	5	120	not evaluable	ROB	-
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Early intrauterine deaths (< 22 weeks) / Spontaneous abortions	0.94 [0.46, 1.91]	0%	2 studies	37	244	not evaluable	ROB	-
Elective/induced termination of pregnancy	1.12 [0.37, 3.40]	-	1 study	14	124	not evaluable	ROB	-
Neuro-developmental disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Neuro-developmental disorders (as a whole)	2.54 [0.23, 28.35]	-	1 study	138	3	not evaluable	ROB	-
Hide endpoints reported in only one study ...